Explore the Parkinson’s research intelligence diagram before entering
the Neurocompute platform.
NC
Neurocompute
AI Parkinson’s Intelligence Terminal
RESEARCH PAPER
SARS-CoV-2 Infection Induces Dopaminergic Neuronal Loss in Midbrain Organoids.
PMID
42178947
Journal
Journal of neurochemistry
Publication Date
2026-05-01
Grade
U
AI Summary
Why It Matters
Abstract
COVID-19 is mainly associated with respiratory symptoms, although several reports show that SARS-CoV-2 affects the nervous system. We evaluated the effects of SARS-CoV-2 infection on human derived midbrain organoids by exposing them to the virus (multiplicity of infection 0.05, 16-h exposure) and analyzing cellular and molecular changes at 4 and 28 days post-infection using immunofluorescence microscopy and RNA sequencing. SARS-CoV-2 nucleocapsid protein preferentially colocalized with tyrosine hydroxylase-positive (TH+) dopaminergic neurons, inducing neurite fragmentation and cellular stress. Transcriptomic analysis revealed dysregulation of pathways related to cell stress and death, DNA damage response, neurodevelopment, and neuronal survival at both timepoints. Persistent alterations in vesicle trafficking, Notch signaling, and mitochondrial function were observed at 28 days post-infection. Analysis of non-coding RNA expression highlighted dysregulated genomic regions associated with viral replication and neurite growth. These findings demonstrate selective vulnerability of dopaminergic neurons to SARS-CoV-2 infection with persistent molecular alterations, providing mechanistic insights into potential neurological consequences of COVID-19.
Score Breakdown
AI Score
-
Base Score
-
Rank Score
-
Narrative Velocity
-
AI Confidence
-
NEUROCOMPUTE VISUAL SYSTEM
Open the Narrative Velocity Map
Explore the full Parkinson’s research intelligence diagram.